Search

everythinglearnresearchcommunity

for

Search:↓

Non-ablative radio frequency can potentially increase hair count in men with androgenetic alopecia, but some may be bothered by the smell during treatment.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

The OVOL1 gene, controlled by β-catenin, is crucial for creating hair follicles.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Low-dose oral minoxidil is effective and well-tolerated for treating hair loss.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Anthralin cream helped 25% of patients with severe alopecia areata regrow hair, but caused skin irritation.

Intralesional steroid injections are safe and effective for treating severe alopecia areata.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Dermal cells are key in controlling hair growth and could potentially be used in hair loss treatments, but more research is needed to improve hair regeneration methods.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Microneedling can effectively promote new hair growth in men with hair loss who didn't improve with traditional treatments.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Minoxidil can reduce functions related to androgen receptors.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.